Haemolytic disease of the newborn
- PMID: 17337672
- PMCID: PMC2675453
- DOI: 10.1136/adc.2005.076794
Haemolytic disease of the newborn
Abstract
The changing management of haemolytic disease of the newborn is reviewed
Conflict of interest statement
Competing interests: None.
Similar articles
-
Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?J Paediatr Child Health. 2013 Dec;49(12):1072-8. doi: 10.1111/jpc.12440. J Paediatr Child Health. 2013. PMID: 24325716 Review.
-
[Haemolytic disease of the newborn (fetus) (author's transl)].Immun Infekt. 1976 Dec;4(6):249-60. Immun Infekt. 1976. PMID: 828142 German.
-
Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).East Mediterr Health J. 2001 Nov;7(6):1065-9. East Mediterr Health J. 2001. PMID: 15332750 No abstract available.
-
Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.J Matern Fetal Neonatal Med. 2004 Sep;16(3):163-6. doi: 10.1080/14767050400009873. J Matern Fetal Neonatal Med. 2004. PMID: 15590442 Clinical Trial.
-
Intravenous immunoglobulin in the management of hemolytic disease of the newborn.Neonatal Netw. 2005 Nov-Dec;24(6):17-24. doi: 10.1891/0730-0832.24.6.17. Neonatal Netw. 2005. PMID: 16383181 Review.
Cited by
-
Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG.J Clin Lab Anal. 2022 Apr;36(4):e24323. doi: 10.1002/jcla.24323. Epub 2022 Mar 3. J Clin Lab Anal. 2022. PMID: 35243688 Free PMC article.
-
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.Br J Haematol. 2022 Jul;198(1):183-195. doi: 10.1111/bjh.18170. Epub 2022 Apr 12. Br J Haematol. 2022. PMID: 35415922 Free PMC article.
-
Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency.Neonatology. 2023;120(5):661-665. doi: 10.1159/000531242. Epub 2023 Jul 20. Neonatology. 2023. PMID: 37473739 Free PMC article.
-
Comparison of the direct antiglobulin test and the eluate technique for diagnosing haemolytic disease of the newborn.Pract Lab Med. 2015 Oct 22;3:17-22. doi: 10.1016/j.plabm.2015.10.001. eCollection 2015 Dec 1. Pract Lab Med. 2015. PMID: 28932805 Free PMC article.
-
Direct antiglobulin test for the prediction of neonatal hyperbilirubinemia needing an intervention: a systematic review and diagnostic test accuracy meta-analysis.Front Pediatr. 2025 Jan 28;12:1475623. doi: 10.3389/fped.2024.1475623. eCollection 2024. Front Pediatr. 2025. PMID: 39935973 Free PMC article.
References
-
- Wang m, Hays T, Ambruso DR, et al Hemolytic disease of the newborn caused by a high titer anti‐group B IgG from a group A mother. Pediatr Blood Cancer 200545861–862. - PubMed
-
- Chen J Y, Ling U P. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua Yi Xue Za Zhi (Taipei) 19945313–18. - PubMed
-
- Oski F A. The erythrocyte and its disorders. In: Nathan A, Oski FA, eds. Hematology of infancy and childhood. Philadelphia: WB Saunders, 199318–43.
-
- Waldron P, de Alarcon P. ABO hemolytic disease of the newborn: a unique constellation of findings in siblings and review of protective mechanisms in the fetal‐maternal system. Am J Perinatol 199916391–398. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical